(Q50905263)
Statements
Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease. (English)
1 reference
Garnero P
1 reference
Gineyts E
1 reference
Schaffer AV
1 reference
Seaman J
1 reference
Delmas PD
1 reference
1 February 1998
1 reference
41
1 reference
2
1 reference
354-360
1 reference